Gallstones in the Era of Metabolic Syndrome: Pathophysiology, Risk Prediction, and Management
Ke Wang,
No information about this author
Zhigang Liu,
No information about this author
Rongmei Tang
No information about this author
et al.
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 13, 2025
Gallstone
disease
(GSD)
and
metabolic
syndrome
(MetS)
are
increasingly
prevalent
conditions
with
significant
global
health
implications.
Recent
evidence
highlights
a
strong
epidemiological
association
between
these
disorders,
driven
by
shared
pathophysiological
mechanisms.
This
review
provides
comprehensive
analysis
of
the
intricate
relationship
MetS
GSD,
focusing
on
role
insulin
resistance,
dyslipidemia,
obesity,
gut
microbiota
dysbiosis
in
gallstone
formation.
An
integrated
model
is
proposed,
linking
disturbances
to
bile
cholesterol
supersaturation,
gallbladder
dysmotility,
chronic
inflammation.
The
also
explores
clinical
implications,
including
risk
prediction
models
based
parameters,
early
detection
biomarkers,
targeted
interventions
such
as
lifestyle
modifications,
pharmacological
therapies,
microbiome
modulation.
By
addressing
underpinnings
this
synthesis
offers
foundation
for
developing
preventive
therapeutic
strategies
mitigate
burden
interconnected
conditions.
Future
research
directions
outlined
refine
mechanistic
insights
improve
outcomes.
Language: Английский
Mammalian Ste20-like kinase 1 regulates AMPK to mitigate the progression of non-alcoholic fatty liver disease
European journal of medical research,
Journal Year:
2025,
Volume and Issue:
30(1)
Published: April 17, 2025
Abstract
Background
Non-alcoholic
steatohepatitis
(NASH)
progression
is
strongly
associated
with
deteriorating
hepatic
function,
primarily
driven
by
free
cholesterol
(FC)
accumulation-induced
lipotoxicity.
Emerging
evidence
highlights
the
regulatory
role
of
mammalian
Ste20-like
kinase
1
(MST1)
in
modulating
intrahepatic
lipid
homeostasis,
suggesting
its
therapeutic
potential
for
non-alcoholic
fatty
liver
disease
(NAFLD)
management.
This
investigation
seeks
to
elucidate
pathophysiological
mechanisms
through
which
MST1
modulates
NASH
progression.
Methods
The
experimental
design
employed
two
murine
genetic
models—wild-type
(WT)
controls
and
MST1-knockout
(MST1-KO)
specimens—subjected
a
nutritionally
modified
Western
diet
(WD)
enriched
saturated
fats,
simple
carbohydrates,
dietary
induce
pathogenesis.
Lentiviral
transduction
techniques
facilitated
targeted
overexpression
WT
animals
maintained
on
this
regimen.
Parallel
vitro
investigations
utilized
HepG2
hepatocyte
cultures
exposed
acid
(FFA)
cocktails
comprising
palmitic
oleic
acids,
coupled
CRISPR-mediated
suppression
complementary
gain-of-function
manipulations
delineate
molecular
mechanisms.
Results
triggers
sterol
biosynthesis
activation,
resulting
pathological
FC
overload
concurrent
transcriptional
suppression.
Genetic
ablation
amplifies
retention
potentiates
histopathological
inflammation,
while
reconstitution
mitigates
steatotic
deposition
attenuates
inflammatory
cascades.
Mechanistic
profiling
revealed
MST1-mediated
AMPKα
phosphorylation
at
Thr172,
suppresses
cholesterogenic
enzyme
expression
via
element-binding
transcription
factor
2
(SREBP2)
axis
modulation.
cascade
demonstrates
dose-dependent
inhibition
HMGCR
activity,
resolving
FC-induced
hepatotoxicity.
Crucially,
orchestrates
AMPK/SREBP2
crosstalk
maintain
knockout
models
exhibiting
67%
elevated
SREBP2
nuclear
translocation
compared
controls.
Conclusions
involving
AMPK
emerges
as
promising
modality
metabolism.
It
significant
arresting
cascades
extracellular
matrix
remodeling
characteristic
studies
confirm
that
effectively
de
novo
lipogenesis
enhancing
efflux
capacity,
thereby
establishing
dual-target
strategy
against
both
metabolic
dysfunction
fibrotic
transformation
preclinical
models.
Language: Английский
Human adaptation response to obesity
International Journal of Obesity,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 27, 2025
Language: Английский
Autolysosomal Dysfunction in Obesity-induced Metabolic Inflammation and Related Disorders
Lenny Yi Tong Cheong,
No information about this author
Eka Norfaishanty Saipuljumri,
No information about this author
Gavin Wen Zhao Loi
No information about this author
et al.
Current Obesity Reports,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: May 14, 2025
Language: Английский
High-Fat Diet and Metabolic Diseases: A Comparative Analysis of Sex-Dependent Responses and Mechanisms
Qiaoling Mo,
No information about this author
Xiao Deng,
No information about this author
Ziyu Zhou
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(10), P. 4777 - 4777
Published: May 16, 2025
Sex
differences
in
metabolic
disorders
and
susceptibility
to
chronic
diseases
induced
by
a
high-fat
diet
(HFD)
exhibit
significant
dimorphic
characteristics.
A
long-standing
male-centric
bias
medical
research
healthcare,
predominantly
focused
on
male
physiological
traits,
has
hindered
the
precise
treatment
of
female
patients.
comprehensive
understanding
sex
health
their
underlying
mechanisms
is
crucial
for
advancing
personalized
promotion
precision
medicine.
This
review
systematically
elucidates
sex-specific
manifestations
diet-associated
disorders:
males
develop
visceral
adiposity,
insulin
resistance,
dyslipidemia,
accompanied
significantly
elevated
risk
cardiovascular
syndromes.
Premenopausal
females
maintain
homeostasis
through
estrogen-mediated
optimization
glucose
lipid
metabolism
oxidative
stress
buffering
mechanisms,
whereas
postmenopausal-phase
experience
dramatic
vulnerability
due
z
loss
protective
barriers.
Furthermore,
we
emphasize
multidimensional
mechanistic
interpretations
sexual
dimorphism
from
perspectives
including
chromosome
complement,
hormone
signaling
pathways,
epigenetic
regulation,
gut
microbiota
composition,
neuroendocrine
dimorphism.
work
provides
critical
theoretical
foundations
rectifying
unisex
paradigms
optimizing
early
warning
systems
therapeutic
strategies
disorders.
Language: Английский